Search
Close this search box.
    • Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.
Syngene wins Asia Pacific Biologics CMO Excellence Awards 2024

Adjudged Best Biologics CMO in South Asia by IMAPAC

Our sustainability journey: Syngene’s comprehensive ESG report 2024
Download ESG Report
Manufacturing the drug substance for Zoetis’ first-in-class mAb osteoarthritis drug
Read Case Study
Syngene achieves silver in EcoVadis ESG assessment

Syngene has been awarded a Silver EcoVadis Medal for FY 2024, placing us among the top 15% of companies assessed.

Read Press Release
Previous slide
Next slide

Who we are

We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply.

What we do

We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements. Our approach enables us to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations.

Discovery

Our Discovery Services span the entire spectrum of early stage research from target …

Development

Our Development Services encompass activities from pre-clinical to clinical trials…

Manufacturing

Our Manufacturing services include cGMP-compliant facilities for clinical supplies, registration batches…

Dedicated Centers

Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support…

InstaVisit – Visit Syngene virtually

Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities. The platform allows you to change your perspective, look around and zoom in as we take you on a guided tour of Syngene’s labs.

Visit Syngene virtually with a 360 degree view of Syngene’s world-class facilities and capabilities
0 +

Active Clients

0

Collaborations with top 20 Pharma/Biotech companies

5200

Scientists

0

Mn sq. ft. of R&D and manufacturing infrastructure

0 +

Patents 

Bharat Eyes Global Biomanufacturing Dominance: Boosting Innovation, Collaboration & Entrepreneurship with BioE3 Policy

News
30th Sep, 2024

Forging Ahead in Formulation

News
22nd Sep, 2024

Syngene expands supply chain with China-free options

News
10th Sep, 2024

Risk assessment strategy for nitrosamine drug substance-related impurities

The potential causes of nitrosamine drug substance-related impurities and Syngene’s strategic framework for identification and management of these impurities to meet regulatory guidelines for product safety.

Innovation at Syngene: Translatable models for improving cancer research

Syngene has developed orthotopic models validated against the standard of care and tumor models with 3D culture, which can help improve translatability and clinical relevance in cancer research.

pDNA and mRNA manufacturing in the age of Precision Therapies: The role of CDMOs

Challenges in pDNA manufacturing and why CDMOs are best suited for supplying pDNA for Precision Therapies.

Upcoming events

6th to 9th Oct
Montreal
9th to 11th Oct
Yokohama
15th to 17th Oct
Basel
16th to 17th Oct
San Diego
20th to 23rd Oct
Utah

Corporate Social Responsibility

To strive towards developing and sustaining healthy and empowered communities by improving the quality of life.

Governance

Behind consistent growth is good governance

Careers

Discover a world of opportunities

Annual Reports

Touching a billon lives through innnovation

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details